In annual report, FDA details how it handled drug shortages in 2022

The FDA said it worked with phar­ma com­pa­nies to pre­vent more than 200 drug short­ages last year. How­ev­er, the reg­u­la­tor still grap­pled with a steady stream of sup­ply is­sues af­fect­ing med­ica­tions rang­ing from amox­i­cillin to Adder­all.

In a re­port that was re­cent­ly made avail­able, and that the FDA is re­quired to put out, the agency cit­ed sev­er­al rea­sons for the 49 drug short­ages it re­port­ed in 2022, in­clud­ing the Covid-19 pan­dem­ic and the en­su­ing dis­rup­tion to the sup­ply chain, man­u­fac­tur­ers hav­ing qual­i­ty and ca­pac­i­ty is­sues, ris­ing de­mand for some med­ica­tions, and an ag­gres­sive flu and RSV sea­son that fur­ther strained the sup­ply chain. About 1,300 po­ten­tial short­ages were re­port­ed by 150 com­pa­nies last year.

To read Endpoints News become a free subscriber

Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters

SIGN UP LOG IN